Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in Italy

ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)

NCT02955615 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus.

NCT01559090 ·Status: COMPLETED ·Phase: PHASE2

A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice

NCT05637112 ·Status: ACTIVE_NOT_RECRUITING

A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)

NCT02550652 ·Status: COMPLETED ·Phase: PHASE2

A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations

NCT02962960 ·Status: COMPLETED ·Phase: PHASE2

A Study of CC312 for Relapsed/Refractory Autoimmune Diseases

NCT07193810 ·Status: RECRUITING ·Phase: EARLY_PHASE1

INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use

NCT06314282 ·Status: RECRUITING

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

NCT05138133 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Anifrolumab Asian PhIII Efficacy Study for Systemic Lupus Erythematosus (SLE)

NCT04931563 ·Status: COMPLETED ·Phase: PHASE3

Bone Mineral Density in Patients with Childhood-onset Systemic Lupus Erythematous, in Relation to Disease Clinical Criteria

NCT06586359 ·Status: NOT_YET_RECRUITING

A Study to Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus.

NCT01031836 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

NCT04895696 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus

NCT04835441 ·Status: COMPLETED ·Phase: PHASE2

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

NCT05531565 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS)

NCT05141201 ·Status: ACTIVE_NOT_RECRUITING

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

NCT07175285 ·Status: RECRUITING

Safety and Efficacy Study of CC312 for Moderate to Severe SLE

NCT07177911 ·Status: RECRUITING ·Phase: PHASE1

Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy Among Patients With SLE

NCT02548936 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

NCT02446912 ·Status: COMPLETED ·Phase: PHASE3

Acthar Gel for Active Systemic Lupus Erythematosus (SLE)

NCT02953821 ·Status: COMPLETED ·Phase: PHASE4

An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis

NCT03385564 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus

NCT04582136 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus

NCT04963296 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Observational Multicenter Case-control Study to Assess Nailfold Capillary Abnormalities in Systemic Lupus Erythematosus

NCT02801812 ·Status: COMPLETED

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:

NCT02890121 ·Status: COMPLETED